2-(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid, 95.0%, 25g

4,7,10,13,16-Pentaoxanonadecane-1,19-dioic acid, 95.0%, 1g

Citrato monopotásico, mínimo 99%, puro, anhidro, 500 g, envase de plástico.

5-Amino-2-(4-methyl-piperazin-1-yl)-benzoic acid, 95.0%, 250mg

4-(furan-2-carbonyl)-8-propyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

1-ethyl-4,5-dihydro-1H-1,2,3,4-tetrazole-5-thione, 98%, 250mg

1,4-DIOXOCANE-5,8-DIONE, 95%, 50mg

3-Bromo-5-(morpholin-4-yl)-7H-thieno[3,2-b]pyran-7-one, 97%, 1g

2-Bromo-4-methyl-benzoic acid ethyl ester, 95.0%, 5g

2-(METHYLAMINO)-6-(TRIFLUOROMETHYL)BENZONITRILE, 95.0%, 5g

N-Methylisatin, 97.0%, 1g

(R)-2-((2-nitrophenoxy)methyl)oxirane, 98%, 1g

TERT-BUTYL 1-CARBAMOYL-6-AZASPIRO[2.5]OCTANE-6-CARBOXYLATE, 95.0%, 100mg